Background: Guidelines support the use of a restrictive strategy in blood transfusion management in a variety of clinical settings. However, recent randomized controlled trials (RCTs) performed in the perioperative setting suggest a beneficial effect on survival of a liberal strategy. We aimed to assess the effect of liberal and restrictive blood transfusion strategies on mortality in perioperative and critically ill adult patients through a meta-analysis of RCTs. Methods: We searched PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials, Transfusion Evidence Library, and Google Scholar up to 27 March 2015, for RCTs performed in perioperative or critically ill adult patients, receiving a restrictive or liberal transfusion strategy, and reporting all-cause mortality. We used a fixed or random-effects model to calculate the odds ratio (OR) and 95% confidence interval (CI) for pooled data. We assessed heterogeneity using Cochrane's Q and I 2 tests. The
Editor's key points
• In this meta-analysis the authors examined the association between blood transfusion strategy (liberal vs conservative) and mortality in perioperative and in critically ill patients receiving critical care.
• They found an extensive evidence base, and the data indicated that a liberal transfusion strategy was associated with improved survival in perioperative (but not critically ill) patients.
Blood transfusion is one of the most frequently used treatments in critically ill and surgical patients. 1 2 Approximately, 85 million red blood cell (RBC) units are transfused worldwide annually. 3 However, observational studies suggest that patients who received RBC transfusion are at increased risk of mortality, infection, and organ dysfunction. 4 5 Moreover, data from recent meta-analyses of randomized controlled trials (RCTs) show that a restrictive transfusion approach is as safe as [6] [7] [8] or even superior 9 to a liberal transfusion approach. Nevertheless, contemporary knowledge should be considered cautiously as the vast majority of published reviews combine results of studies conducted in different clinical contexts: adults, children, surgical, and critically ill patients. Recently published RCTs in cardiac surgery, 10 oncology, 11 and hip fracture surgery 12 raised the possibility that mortality is lower using a liberal transfusion strategy when compared with a restrictive strategy. Therefore, we performed a meta-analysis of RCTs to investigate the influence of liberal and restrictive blood transfusion strategies on mortality in perioperative and critically ill adult patients.
Methods

Search strategy
We searched PubMed/Medline, Embase, Cochrane Central Register of Controlled Trials, Transfusion Evidence Library, and Google Scholar for relevant studies up to 27 March 2015, with keyword search terms including 'blood transfusion', 'red blood cell', 'RBC', 'transfusion', 'trigger', 'threshold', 'strategy', 'liberal', and 'restrictive'. The full PubMed search strategy is available in the supplement (Supplementary Digital Content 1). We also searched reference lists of selected articles, conference proceedings, and personal files for relevant citations. We screened ClinicalTrials.gov to ensure identification of relevant ongoing studies. We used no language restrictions. This systematic review included studies with the following eligibility criteria: (1) population: patients aged more than 18 yr who were in the perioperative period or had critical illness; (2) intervention: allogeneic blood transfusion with the use of liberal (higher transfusion threshold) in one group and restrictive (lower transfusion threshold) protocol in the other group. Thresholds for transfusion were: haemoglobin or haematocrit concentrations, transfusion practice or predefined protocol; (3) outcome: all-cause mortality; (4) study design: randomized controlled trial. We excluded conferences proceedings if the abstracts were not published as full articles in the following 3 yr.
Data extraction and quality assessment
This study was performed at the Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy. Two researchers screened the citations identified by the search strategies. Full text review was done to establish eligibility when screening reviewers believed that a citation potentially met inclusion criteria. Disagreements regarding inclusion were reconciled via consensus.
Two reviewers independently extracted data from the list of included studies. Details of the study design, clinical settings, patient characteristics, transfusion triggers, and mortality were collected. The methodological quality of individual studies (including description of randomization, allocation concealment, blinded assessor, and intention-to-treat data analysis) was assessed. We rated the risk of bias by applying a rating of 'Yes', 'No' or 'Unclear' to denote whether adequate measures were taken to protect against each potential source of bias in each study. The overall risk of bias was expressed as low, moderate, or high.
Data analysis
The primary outcome was 90-day all-cause mortality. If 90-day mortality was not reported we chose the closest mortality data available and reported the follow-up in Table 1 . All analyses were done with Review Manager (RevMan, Version 5.3., Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). We employed the Mantel-Haenszel method with fixedeffect model when the heterogeneity was less than 50%, according to Higgins's I 2 test and the P value for Cochrane's Q test had a critical level of significance more than 10%. We used odds ratios (ORs) to pool outcome with a two-sided significance level of 5%. Individual trial and summary results are reported with 95% confidence intervals (CIs). Data from each trial were considered as per the intention-to-treat principle. We also calculated the number needed to treat (NNT). To compare different groups ( perioperative and critically ill) with each other, we performed tests for subgroup differences based on random-effects models. To assess for publication bias, we visually examined a funnel plot comparing effect measure for the primary outcome of mortality with study precision for evidence of asymmetry and applied both the Egger's and Begg's regression tests using the metabias command in STATA (StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP). We performed sensitivity analyses by sequentially removing each study result from the pooled effect estimate. We also repeated analysis including only trials with low risk of bias, with multi-centre design, or trials enrolling more than 100 patients.
Results
Characteristics of included studies
The initial search strategy identified 10 045 citations (Fig. 1 10 18 Leucocyte reduced blood was administered in 11 . *Symptoms or consequences of anaemia which were defined as chest pain thought to be cardiac in origin; myocardial infarction; congestive heart failure; unexplained tachycardia, hypotension, or decreased urine output that was unresponsive to fluid replacement. † Symptoms of anaemia included definite angina requiring treatment with sublingual nitroglycerin, and unexplained tachycardia or hypotension. ‡ Symptoms of anaemia were recurrent vaso-vagal episodes on mobilization, chest pain of cardiac origin, congestive cardiac failure, unexplained tachycardia, hypotension or dyspnoea, decreased urine output unresponsive to fluid replacement.
#
In restrictive group transfusion policy considering age, time since surgery, cardiovascular comorbidities, pulmonary diseases and diabetes mellitus. In liberal group standard care transfusion policies.
¶ Until intracranial pressure monitoring and ventilator support were no longer required. Blood was also given in case of haemodynamic instability because of active bleeding The majority of trials reported an appropriate method of randomization. Concealment of allocation was documented in 19 trials. Owing to the nature of interventions used, none of the trials was blinded. However, 14 trials attempted to blind the data collectors. Twenty-six trials presented the results as intention to treat. According to methodological assessment, 13 trials had low, 11 trials had moderate and 2 trials had high risk of bias (Supplementary Table S1 in Supplementary Digital Content 1).
Quantitative data synthesis
Overall, there was no difference in mortality between the liberal and the restrictive transfusion strategy OR 0.96; 95% CI 0.78-1.18; P for effect=0.68 ( Supplementary Fig. S1 in Supplementary Digital Content 1) with no changes when performing sensitivity analyses ( Supplementary Fig. S4 ) and sub-analyses (Supplementary  Table S2 In the perioperative setting all-cause mortality was reduced in patients randomized to receive a liberal transfusion strategy when compared with those receiving a restrictive transfusion strategy OR 0.81; 95% CI 0.66-1.00; P for effect=0.05; NNT=97 ( Fig. 2) (P=0.39), and Begg's test (P=0.86), showed no evidence of small study publication bias. In the critically ill setting there was no difference in all-cause mortality in patients randomized to receive a liberal transfusion strategy when compared with those receiving a restrictive transfusion strategy OR 1.10; 95% CI 0.99-1.23; P for effect=0.07 (Fig. 4) 
Discussion
The most important finding of this meta-analysis of RCTs is to suggest that the effect of transfusion strategies on patients'
survival depends on the studied setting. In adult perioperative patients a restrictive strategy seems to be detrimental and to increase mortality. In critically ill patients there was no difference in mortality, we revealed only the trend in favour of restrictive strategy. While a restrictive transfusion strategy is endorsed by several guidelines [37] [38] [39] especially because of reduced resource utilization, the increase in mortality with a restrictive strategy in the perioperative setting is a novel finding. Heterogeneity in blood transfusion management exists despite the recommendation of several guidelines for a restrictive (rather than liberal) strategy for blood management in various clinical environments. [37] [38] [39] It should be noted that some of the clinical practice guidelines have a low level of evidence and are based on expert opinion. 37 Other guidelines based their suggestions using the evidence coming from a single RCT 38 or based their assumption on previous guidelines. 39 The updated guidelines by the American Society of Anesthesiologists task force on perioperative blood management, concluded that a restrictive RBC transfusion strategy may be used to reduce the usage of blood products, while recognizing that findings for mortality, cardiac, neurologic and pulmonary complications, and length of hospital stay were equivocal.
40
Large multicentre RCTs in critically ill patients with normovolaemia (TRICC), 25 in patients with septic shock (TRISS), 26 in high-risk patients after hip surgery (FOCUS), 18 and one large single-centre RCT in elective cardiac surgery patients (TRACS) 23 showed similar rates of mortality between patients with restrictive and liberal transfusion strategies. These RCTs influenced the general recommendation for preferable use of restrictive strategy over liberal transfusion in the above mentioned guidelines. However, the results of these trials should be interpreted cautiously. The TRICC and FOCUS trials had low level of enrolment of the eligible patients that raises concerns about selection bias. In the TRICC, TRACS, and TRISS trials patients in the restrictive group were transfused at haemoglobin concentrations that were higher than that of the protocolized thresholds. Our findings are different from those of five previously published meta-analyses. We are the first to document a mortality reduction with the use of a liberal transfusion strategy in patients in the perioperative period. This difference is driven by the inclusion in our meta-analysis of three RCTs [10] [11] [12] independently showing a mortality reduction in this setting when using a liberal approach. Furthermore, we limited our analysis to adult patients and we were the first to focus on the perioperative setting. A 2012 Cochrane review of RCTs showed that patients receiving liberal transfusion had higher in-hospital mortality compared with those with restrictive strategy, 6 but 97% of weight for in-hospital mortality outcome derived from only two trials (TRICC and FOCUS). The meta-analysis of three RCTs by Salpeter and colleagues 9 revealed higher mortality in a mixed population with liberal strategy compared with restrictive of <7 g dl −1 including paediatric and adult patients. A meta-analysis of seven RCTs in adult patients undergoing cardiovascular surgery did not determine any difference in mortality between liberal and restrictive blood transfusion strategies. 7 Chatterjee and colleagues 41 summarized the findings from one RCT and nine observational trials in patients with an acute myocardial infarction and showed that blood transfusion was associated with higher mortality. However, this study was not able to adequately manage the unbalance in patients' characteristics in the included trials and there was a great interdependence in the level of pooled risk from anaemia or from blood transfusions. Nevertheless, our findings are in accordance with the results of a recently published large multicentre RCT in nonemergency cardiac surgery. 10 Patients were randomized to receive transfusion when their haemoglobin concentration was less than 9 g dl −1 or when it was less than 7.5 g dl −1 . There was no difference between the groups in terms of morbidity. However, 90-day mortality rate was significantly higher in the restrictive compared with the liberal transfusion group (4.2% vs 2.6%; hazard ratio 1.64; 95% CI: 1.00-2.67; P=0.045).
In our meta-analysis we investigated mortality in RCTs of blood transfusion strategy taking into account the important role of the clinical context. Because of pathophysiological differences between surgery and critical illness, outcome data associated with RBCs transfusions and the thresholds cannot be generalized. Important differences exist in the anaemia of surgical patients and of critically ill patients, whose haemoglobin deficit is more than simply acute blood loss. Repeated phlebotomies, gastrointestinal blood loss, and invasive procedures significantly contribute to the development of anaemia in critical illness together with coagulopathies, pathogen-associated haemolysis, blunted erythropoietin production and erythropoietin response, abnormalities in iron metabolism, and nutritional deficiencies. In contrast, surgical blood loss and haemodilution are important determining factors in patients' intra-and postoperative haemoglobin concentration. [43] [44] [45] Anaemia in perioperative settings is often an acute event, while in critically ill patients it has chronic pattern in the majority of the patients. The ability to tolerate anaemia will depend in part on how quickly compensatory mechanisms develop. 43 Moreover, a surgical population does not typically have the same baseline extent of organ dysfunction.
Strengths and limitations
In few trials, mortality data were not properly reported (Supplementary Digital Content 1) and this led to their exclusion from the meta-analysis; nonetheless, we were able to include 27 trials with more than 11 000 patients and this is the largest meta-analysis on this topic performed to date. We combined data from trials performed in different clinical settings (e.g. cardiac surgery is different from orthopaedic surgery) and that varied in triggers for blood transfusion (in one study 12 the restrictive trigger was higher than the liberal trigger in other trials), but this is a bias that cannot be overcome 46 and that was present in previously published meta-analyses. 6 8 There was incomplete blinding of the participants in the individual trials because of the nature of the intervention. Nonetheless, we assessed the most clinically relevant endpoint and we give physicians an important message. Future international guidelines should take into account the possibility that a restrictive transfusion strategy could have an opposite effect on survival in critically ill patients and in the perioperative period, as suggested by our findings (P=0.03 for mortality when comparing these two settings). A liberal transfusion strategy will probably be included among the few topics with randomized evidence of perioperative mortality reduction. 47 In conclusion, the present meta-analysis of RCTs demonstrates the importance of the clinical setting when RBCs transfusion strategies are considered. Within a perioperative adult surgical population, a liberal blood transfusion strategy reduces all-cause mortality when compared with a restrictive strategy. 
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